Boniva Patent Lawsuits Follow Roche's Patent Award

摘要

Roche is suing several generic firms for infringing on a recently awarded patent covering the company's once-monthly osteoporosis drug Boniva. Roche alleges that Orchid Chemicals & Pharmaceuticals, Teva Pharmaceuticals, Gate Pharmaceuticals, Cobalt Pharmaceuticals, Apo-tex, Genpharm and Dr. Reddy's will infringe on the '957 patent covering Boniva (ibandronate sodium) 150-mg formulation if they manufacture, market or import their proposed generic products in the U.S. before Roche's patent expires in May 2023. The action is pending before the U.S. District Court for the District of New Jersey.